ID   MBOA2_RAT               Reviewed;         519 AA.
AC   Q3T1J2;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   24-JUL-2024, entry version 101.
DE   RecName: Full=Lysophospholipid acyltransferase 2 {ECO:0000250|UniProtKB:Q6ZWT7};
DE            Short=LPLAT 2;
DE            EC=2.3.1.- {ECO:0000250|UniProtKB:Q6ZWT7};
DE   AltName: Full=1-acylglycerophosphate O-acyltransferase;
DE            EC=2.3.1.51 {ECO:0000250|UniProtKB:Q6ZWT7};
DE   AltName: Full=1-acylglycerophosphocholine O-acyltransferase {ECO:0000250|UniProtKB:Q6ZWT7};
DE            EC=2.3.1.23 {ECO:0000250|UniProtKB:Q6ZWT7};
DE   AltName: Full=1-acylglycerophosphoethanolamine O-acyltransferase {ECO:0000250|UniProtKB:Q6ZWT7};
DE            EC=2.3.1.n7 {ECO:0000250|UniProtKB:Q6ZWT7};
DE   AltName: Full=Lysophosphatidic acid acyltransferase;
DE            Short=LPAAT;
DE            Short=Lyso-PA acyltransferase;
DE   AltName: Full=Lysophosphatidylcholine acyltransferase;
DE            Short=LPCAT;
DE            Short=Lyso-PC acyltransferase;
DE   AltName: Full=Lysophosphatidylcholine acyltransferase 4;
DE            Short=Lyso-PC acyltransferase 4;
DE   AltName: Full=Lysophosphatidylethanolamine acyltransferase;
DE            Short=LPEAT;
DE            Short=Lyso-PE acyltransferase;
DE   AltName: Full=Membrane-bound O-acyltransferase domain-containing protein 2;
DE            Short=O-acyltransferase domain-containing protein 2;
GN   Name=Mboat2 {ECO:0000312|RGD:1305798}; Synonyms=Oact2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Acyltransferase which catalyzes the transfer of an acyl group
CC       from an acyl-CoA to a lysophospholipid leading to the production of a
CC       phospholipid and participates in the reacylation step of the
CC       phospholipid remodeling pathway also known as the Lands cycle. May
CC       catalyze preferentially the acylation of lysophosphatidylethanolamine
CC       (1-acyl-sn-glycero-3-phosphoethanolamine or LPE) and lysophosphatidic
CC       acid (LPA) and to a lesser extend lysophosphatidylcholine (LPC) and
CC       lysophosphatidylserine (LPS). Prefers oleoyl-CoA as the acyl donor (By
CC       similarity). May be involved in chondrocyte differentiation (By
CC       similarity). {ECO:0000250|UniProtKB:Q6ZWT7,
CC       ECO:0000250|UniProtKB:Q8R3I2}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphocholine + an acyl-CoA = a 1,2-
CC         diacyl-sn-glycero-3-phosphocholine + CoA; Xref=Rhea:RHEA:12937,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57643, ChEBI:CHEBI:58168,
CC         ChEBI:CHEBI:58342; EC=2.3.1.23;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12938;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphoethanolamine + an acyl-CoA = a
CC         1,2-diacyl-sn-glycero-3-phosphoethanolamine + CoA;
CC         Xref=Rhea:RHEA:32995, ChEBI:CHEBI:57287, ChEBI:CHEBI:58342,
CC         ChEBI:CHEBI:64381, ChEBI:CHEBI:64612; EC=2.3.1.n7;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32996;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphate + an acyl-CoA = a 1,2-diacyl-
CC         sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:19709,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57970, ChEBI:CHEBI:58342,
CC         ChEBI:CHEBI:58608; EC=2.3.1.51;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19710;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-hexadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-
CC         phosphocholine = 1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-
CC         phosphocholine + CoA; Xref=Rhea:RHEA:37207, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:61540, ChEBI:CHEBI:72998, ChEBI:CHEBI:74000;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37208;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-
CC         phosphoethanolamine = 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-
CC         3-phosphoethanolamine + CoA; Xref=Rhea:RHEA:36015, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:73004, ChEBI:CHEBI:73007;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36016;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-hexadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-
CC         phosphoethanolamine = 1-hexadecanoyl-2-(9Z)-hexadecenoyl-sn-glycero-
CC         3-phosphoethanolamine + CoA; Xref=Rhea:RHEA:37419, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:61540, ChEBI:CHEBI:73004, ChEBI:CHEBI:73999;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37420;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phospho-L-serine +
CC         hexadecanoyl-CoA = 1-(9Z)-octadecenoyl-2-hexadecanoyl-sn-glycero-3-
CC         phosphoserine + CoA; Xref=Rhea:RHEA:37415, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57379, ChEBI:CHEBI:74617, ChEBI:CHEBI:74909;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37416;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + 1-hexadecanoyl-sn-glycero-3-
CC         phosphocholine = 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-
CC         glycero-3-phosphocholine + CoA; Xref=Rhea:RHEA:35995,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57383, ChEBI:CHEBI:72998,
CC         ChEBI:CHEBI:73002; Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35996;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-
CC         phosphocholine = 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphocholine + CoA; Xref=Rhea:RHEA:35991, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:72998, ChEBI:CHEBI:73001;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35992;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-hexadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-phosphate
CC         = 1-hexadecanoyl-2-[(9Z)-hexadec-9-enoyl]-sn-glycero-3-phosphate +
CC         CoA; Xref=Rhea:RHEA:37223, ChEBI:CHEBI:57287, ChEBI:CHEBI:57518,
CC         ChEBI:CHEBI:61540, ChEBI:CHEBI:73998;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37224;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-phosphate
CC         = 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:33187, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:57518, ChEBI:CHEBI:64839;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33188;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWT7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-O-(1Z-alkenyl)-sn-glycero-3-
CC         phosphocholine = 1-O-(1Z)-alkenyl-2-(9Z)-octadecenoyl-sn-glycero-3-
CC         phosphocholine + CoA; Xref=Rhea:RHEA:37627, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:77287, ChEBI:CHEBI:77294;
CC         Evidence={ECO:0000250|UniProtKB:Q8R3I2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37628;
CC         Evidence={ECO:0000250|UniProtKB:Q8R3I2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-O-(1Z-alkenyl)-sn-glycero-3-
CC         phosphoethanolamine = 1-O-(1Z)-alkenyl-2-(9Z)-octadecenoyl-sn-
CC         glycero-3-phosphoethanolamine + CoA; Xref=Rhea:RHEA:37631,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:77288,
CC         ChEBI:CHEBI:77291; Evidence={ECO:0000250|UniProtKB:Q8R3I2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37632;
CC         Evidence={ECO:0000250|UniProtKB:Q8R3I2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-octadecanoyl-sn-glycero-3-
CC         phosphoethanolamine = 1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-
CC         3-phosphoethanolamine + CoA; Xref=Rhea:RHEA:37523, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:75036, ChEBI:CHEBI:75038;
CC         Evidence={ECO:0000250|UniProtKB:Q8R3I2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37524;
CC         Evidence={ECO:0000250|UniProtKB:Q8R3I2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-octadecanoyl-sn-glycero-3-
CC         phosphocholine = 1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphocholine + CoA; Xref=Rhea:RHEA:37519, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:73858, ChEBI:CHEBI:75034;
CC         Evidence={ECO:0000250|UniProtKB:Q8R3I2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37520;
CC         Evidence={ECO:0000250|UniProtKB:Q8R3I2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoethanolamine = 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoethanolamine + CoA; Xref=Rhea:RHEA:37499, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:74971, ChEBI:CHEBI:74986;
CC         Evidence={ECO:0000250|UniProtKB:Q8R3I2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37500;
CC         Evidence={ECO:0000250|UniProtKB:Q8R3I2};
CC   -!- ACTIVITY REGULATION: Partially inhibited by thimerosal.
CC       {ECO:0000250|UniProtKB:Q6ZWT7}.
CC   -!- PATHWAY: Lipid metabolism; phospholipid metabolism.
CC       {ECO:0000250|UniProtKB:Q6ZWT7}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q6ZWT7}; Multi-
CC       pass membrane protein {ECO:0000250|UniProtKB:Q6ZWT7}. Endoplasmic
CC       reticulum {ECO:0000250|UniProtKB:Q8R3I2}.
CC   -!- SIMILARITY: Belongs to the membrane-bound acyltransferase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BC101889; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03049793; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03054282; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03052483; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03050975; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03049616; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC101889; -; NOT_ANNOTATED_CDS; mRNA.
DR   RefSeq; NP_001101486.2; NM_001108016.2.
DR   AlphaFoldDB; Q3T1J2; -.
DR   SMR; Q3T1J2; -.
DR   STRING; 10116.ENSRNOP00000075292; -.
DR   PhosphoSitePlus; Q3T1J2; -.
DR   PaxDb; 10116-ENSRNOP00000009018; -.
DR   Ensembl; ENSRNOT00000082657.2; ENSRNOP00000075292.1; ENSRNOG00000061050.2.
DR   Ensembl; ENSRNOT00055009131; ENSRNOP00055006974; ENSRNOG00055005667.
DR   Ensembl; ENSRNOT00060013322; ENSRNOP00060010132; ENSRNOG00060008049.
DR   Ensembl; ENSRNOT00065016698; ENSRNOP00065012741; ENSRNOG00065010325.
DR   GeneID; 313997; -.
DR   KEGG; rno:313997; -.
DR   AGR; RGD:1305798; -.
DR   CTD; 129642; -.
DR   RGD; 1305798; Mboat2.
DR   eggNOG; KOG2704; Eukaryota.
DR   GeneTree; ENSGT01030000234564; -.
DR   HOGENOM; CLU_011340_3_0_1; -.
DR   InParanoid; Q3T1J2; -.
DR   OMA; ASWPIRF; -.
DR   OrthoDB; 5297955at2759; -.
DR   PhylomeDB; Q3T1J2; -.
DR   TreeFam; TF314906; -.
DR   Reactome; R-RNO-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-RNO-1482839; Acyl chain remodelling of PE.
DR   UniPathway; UPA00085; -.
DR   PRO; PR:Q3T1J2; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000061050; Expressed in esophagus and 16 other cell types or tissues.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047184; F:1-acylglycerophosphocholine O-acyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0106262; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0106263; F:1-acylglycerophosphoserine O-acyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0016746; F:acyltransferase activity; IBA:GO_Central.
DR   GO; GO:0030258; P:lipid modification; IBA:GO_Central.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; ISS:UniProtKB.
DR   GO; GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; ISS:UniProtKB.
DR   GO; GO:0036150; P:phosphatidylserine acyl-chain remodeling; ISS:UniProtKB.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0032330; P:regulation of chondrocyte differentiation; ISS:UniProtKB.
DR   InterPro; IPR049941; LPLAT_7/PORCN-like.
DR   InterPro; IPR004299; MBOAT_fam.
DR   PANTHER; PTHR13906:SF7; LYSOPHOSPHOLIPID ACYLTRANSFERASE 2; 1.
DR   PANTHER; PTHR13906; PORCUPINE; 1.
DR   Pfam; PF03062; MBOAT; 1.
PE   2: Evidence at transcript level;
KW   Acyltransferase; Endoplasmic reticulum; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Phospholipid biosynthesis;
KW   Phospholipid metabolism; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..519
FT                   /note="Lysophospholipid acyltransferase 2"
FT                   /id="PRO_0000273022"
FT   TRANSMEM        22..42
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        61..81
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        88..108
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        184..204
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        236..256
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        288..305
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        365..385
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        415..435
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        443..463
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        341
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        372
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   519 AA;  59001 MW;  D5CAFBD16F7642B3 CRC64;
     MATTSTTGST LLQPLSNAVQ LPIDQVNFVV CQLFALLAAV WFRTYLHSSK TSSFIRHVVA
     TLLGLYLAFF CFGWYALHFL VQSGISYCIM IIAGVESMHQ CCFVFALGYL SVCQITRVYI
     FDYGQYSADF SGPMMIITQK ITSLAYEIHD GMFRKDEELT PSQRGLAVRR MPSLLEYVSY
     TCNFMGILAG PLCSYKDYIA FIEGRASHMA QSGENGKEEQ HGKAEPSPNA AVTEKLLVCG
     LSLLFHLTIS SMLPVEYNID EHFQATASWP TKATYLYVSL LAARPKYYFA WTLADAINNA
     AGFGFRGYDK NGVARWDLIS NLRIQQIEMS TSFKMFLDNW NIQTALWLKR VCYERATFSP
     TVQTFFLSAI WHGVYPGYYL TFLTGVLMTL AARAVRNNFR HYFVEPPQLK LFYDIITWAA
     TQITISYTVV PFVLLSINPS FTFYRSWYYC LHICSILVLL LLPVKKSPRK KNTEENAQPS
     WAKKFDEREN SLGQNSFSMM NNVCNQNQDT GSRHSALTQ
//
